Earlier this summer, Monsanto twice offered to buy Syngenta for $45 million. Why would the US based chemical giant want to buy out its arch rival in Switzerland? The answer…
Carey Danis LoweAugust 17, 2015
OUR MOST RECENT POSTS
BLOG & NEWS CATEGORIES
- 401(K) Litigation
- Actos
- ATV Accidents
- Auto Accidents
- bad faith
- Brain Injuries
- Burn Injuries
- Bus Accidents
- Class Action
- Commercial Litigation
- Consumer protection
- Dangerous Drugs
- Defective Medical Device litigation
- Depakote
- Drug Safety
- Fda Categories in St. Louis
- GMO
- Highway Safety
- Hip/Knee Replacement
- Invokana
- IVC Filters
- Jury Verdicts
- Laws
- Levaquin
- Lexapro
- Lost Wages
- Medical Malpractice
- Mirena
- Missouri Legal Decisions
- Missouri Verdicts and Settlements
- Monsanto
- Negligence
- NuvaRing
- Paxil
- Personal Injury
- Pharmaceutical litigation
- Pradaxa
- Predatory Lending
- Premises Liability
- Product Liability
- Prozac
- Recalls
- Reglan
- Risperdal
- Settlements
- St. Louis Mass Torts
- Testosterone
- Texting & Driving
- Topamax
- Traffic Safety
- Transvaginal Mesh
- Trucking Accidents
- Trucking Laws
- Trucking Regulations
- Uncategorized
- Unfair Deceptive Trades
- Verdicts and Settlements
- Wellbutrin
- Wrongful Death
- Yaz/Yasmin
- Zofran
- Zoloft
Tags
Actos American Medical Systems antidepressant Bayer birth control birth defects bladder cancer blood clots Boston Scientific Boston Scientific Corp C.R. Bard Carey Carey Danis Carey Danis Lowe class action contraceptive Danis Danis Lowe defective DePuy District Court Ethicon FDA heart attack Johnson Johnson Judge Goodwin lawsuit litigation Lowe MDL metal on metal New Jersey POP Press Release recall side effects SSRI St. Louis surgery transvaginal mesh United States West Virginia Yasmin Yaz Zoloft